Minimum Effective Dosages of Anti-TNF in Rheumatoid Arthritis: A Cross-sectional Study Inmaculada de la Torre, Lara Valor, Juan Carlos Nieto, María Montoro, Luis Carreño

Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure Francisco J. Blanco, Esteban Rubio-Romero, Raimon Sanmartí, César Díaz-Torné, Pablo Talavera, Jochen Dunkel, Esperanza Naredo

Factors contributing to disability in rheumatoid arthritis patients: An Egyptian multicenter study Marwa Hammad, Mervat Eissa, Ghada A. Dawa